Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis

Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis

BACKGROUND: Angiopoietin-2 (Ang-2) plays a pivotal role in pathological vascular remodeling and angiogenesis. Both vascular mechanisms are active in patients with end-stage renal disease (ESRD) and may contribute to the high mortality in these patients. The aim of this multicenter prospective cohort...

Full description

Bibliographic Details
Main Authors: Chen, X. (Author), Chu, C. (Author), Hasan, A.A (Author), Hocher, B. (Author), Krämer, B.K (Author), Szakallova, A. (Author), Tepel, M. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
adverse event
all-cause mortality
angiopoietin 2
angiopoietin-2
Angiopoietin-2
chronic kidney failure
clinical trial
female
Female
hemodialysis
hemodialysis patients
human
Humans
Kidney Failure, Chronic
male
Male
multicenter study
proportional hazards model
Proportional Hazards Models
Prospective Studies
prospective study
Renal Dialysis
sex-dependent impact
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items